News

A comprehensive review of high-quality studies found no evidence that prenatal paracetamol use increases the risk of autism, ADHD, or intellectual disability.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Increasing numbers, complexity, and severity of maternal chronic conditions are associated with a dose-response rise in severe neonatal morbidity and mortality.

Youth suicide data highlight firearm safety counseling and universal screening as key prevention tools, especially for youth without prior mental health contact.

A study found that children with both a low 5-minute Apgar score and low umbilical cord blood pH at birth had an increased risk of ADHD.

In a recent study, targeted sodium supplementation guided by urine sodium levels was associated with improved early weight gain in very preterm infants.

AAP policy outlines when pediatricians may provide care to parents during child visits, emphasizing benefits, legal considerations, and documentation safeguards.

AAP updates guidance on children’s digital media use, urging child-centered design and system-level action beyond screen time limits.

Prescribing increased after adolescent approval but remains uncommon.

Cardiovascular risk factors beginning in infancy may influence cognitive function by young adulthood, highlighting the importance of early heart health promotion.

Three-year EMBARK data show ELEVIDYS slows functional decline in ambulatory Duchenne patients, extending earlier 2-year efficacy findings.

More than half of infants with myelomeningocele experience sleep-disordered breathing before hospital discharge, with prematurity driving risk.

A study found that a deep learning model using baseline fundus images can accurately predict myopia progression and high myopia risk.

A study found that individuals with ADHD traits in childhood had increased odds of physical multimorbidity and disability by midlife.

Eye-tracking technology revolutionizes autism diagnosis, enabling earlier detection and intervention for children, enhancing clinical efficiency and accuracy.

A study found that nonmedical childhood vaccine exemptions have increased significantly across US counties since 2010.

FDA accepted centanafadine NDA for priority review, supported by phase 3 trials showing efficacy in children, adolescents, and adults with ADHD.

A study found significant gaps in sudden unexpected death in epilepsy awareness and risk management.

AAP updated guidance supports therapeutic hypothermia for term infants with moderate to severe HIE, emphasizing early initiation and specialized care.

Advances in next-generation sequencing are expanding the ability of newborn screening programs to detect genetic diseases earlier.

Caregivers with food insecurity balance prior lifestyle experiences, trust in newer medications, and deeply held beliefs about child health when considering GLP-1 receptor agonists.

The AAP released its 2026 childhood immunization schedule, maintaining evidence-based vaccine recommendations and expanding guidance across routine, catch-up, and risk-based care.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Findings from phase 3 SHORE and COAST 2 trials showed amlitelimab met key efficacy end points in moderate to severe atopic dermatitis, supporting planned regulatory submissions.

AnnaLynn M. Williams, PhD; and Kevin Krull, PhD, discuss accelerated biologic aging in childhood cancer survivors.

FDA-cleared Flowflex Plus 4-in-1 home test detects RSV, influenza A/B, and COVID-19 in adults and children as young as 6 months.

Researchers identified 5 distinct classifications of youth suicide, revealing that nearly half of cases had no prior clinical contact or documented risk.

Results from a large US cohort study found no association between community water fluoridation and birth weight, providing reassurance about exposure during pregnancy.